EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 2 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,193 | +78.4% | 75,133 | +295.4% | 0.00% | – |
| Q2 2023 | $140,250 | -36.3% | 19,004 | -10.1% | 0.00% | – |
| Q1 2023 | $220,185 | -31.5% | 21,131 | -24.1% | 0.00% | – |
| Q4 2022 | $321,480 | -36.7% | 27,846 | +73.5% | 0.00% | -100.0% |
| Q2 2022 | $508,000 | -39.6% | 16,053 | -20.4% | 0.00% | 0.0% |
| Q1 2022 | $841,000 | +120.2% | 20,169 | +134.5% | 0.00% | – |
| Q4 2021 | $382,000 | -90.1% | 8,600 | -80.1% | 0.00% | -100.0% |
| Q4 2020 | $3,876,000 | -36.0% | 43,277 | -26.1% | 0.01% | -50.0% |
| Q3 2020 | $6,057,000 | +815.0% | 58,585 | +599.5% | 0.01% | +900.0% |
| Q2 2020 | $662,000 | +48.8% | 8,375 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $445,000 | +99.6% | 7,692 | +73.4% | 0.00% | – |
| Q1 2019 | $223,000 | – | 4,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |